Rhode Island College

Digital Commons @ RIC
Master's Theses, Dissertations, Graduate
Research and Major Papers Overview

Master's Theses, Dissertations, Graduate
Research and Major Papers

12-1-2019

The Impact of Intrathecal Dexmedetomidine as an Adjuvant to
Bupivacaine on Postoperative Pain
Stephanie Wilson

Follow this and additional works at: https://digitalcommons.ric.edu/etd
Part of the Nursing Commons

Recommended Citation
Wilson, Stephanie, "The Impact of Intrathecal Dexmedetomidine as an Adjuvant to Bupivacaine on
Postoperative Pain" (2019). Master's Theses, Dissertations, Graduate Research and Major Papers
Overview. 322.
https://digitalcommons.ric.edu/etd/322

This Major Paper is brought to you for free and open access by the Master's Theses, Dissertations, Graduate
Research and Major Papers at Digital Commons @ RIC. It has been accepted for inclusion in Master's Theses,
Dissertations, Graduate Research and Major Papers Overview by an authorized administrator of Digital Commons
@ RIC. For more information, please contact digitalcommons@ric.edu.

THE IMPACT OF INTRATHECAL DEXMEDETOMIDINE AS AN ADJUVANT TO
BUPIVACAINE ON POSTOPERATIVE PAIN

A Major Paper Presented
by
Stephanie Wilson

Approved:
Committee Chairperson

_________________________________

__________
(Date)
Committee Members
_________________________________ __________
(Date)
_________________________________ __________
(Date)
Director of Master’s Program _________________________________ __________
(Date)
Dean, School of Nursing
_________________________________ __________
(Date)

THE IMPACT OF INTRATHECAL DEXMEDETOMIDINE AS AN ADJUVANT TO
BUPIVACAINE ON POSTOPERATIVE PAIN

by
Stephanie Wilson
A Major Paper Submitted in Partial Fulfillment
of the Requirements for the Degree of
Master of Science in Nursing
in
The School of Nursing
Rhode Island College
2019

Abstract
Postoperative pain is an unpleasant consequence of all surgical procedures. It is an
unpleasant sensory and emotional experience associated with actual or potential tissue
damage. There are many negative consequences to postoperative pain including delayed
recovery, increased healthcare costs, and overall dissatisfaction with care. There are
many methods to minimize postoperative pain. Spinal anesthesia has been used for years
to improve postoperative pain across a variety of surgical procedures. New research has
shown that the use of adjuvant medications with intrathecal bupivacaine greatly improves
postoperative pain. One adjuvant medication is dexmedetomidine. The purpose of this
systematic review was to determine if the administration of intrathecal dexmedetomidine,
as an adjuvant medication to bupivacaine, impacts postoperative pain in adult patients
undergoing surgery. A literature review was conducted using the PRISMA flow diagram.
Data was then collected from each study and a cross study analysis was conducted.
Findings indicated, in all studies, the addition of dexmedetomidine to intrathecal
bupivacaine decreased postoperative pain levels. Integration of dexmedetomidine into
spinal anesthesia can make an immense difference in postoperative analgesia and
recovery, an important consideration for anesthesia providers.
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The Impact of Intrathecal Dexmedetomidine as an Adjuvant to Bupivacaine on
Postoperative Pain
Background/Statement of the Problem
Postoperative analgesia is a substantial and current issue in the healthcare field
today. Unfortunately, postoperative pain is inadequately managed in greater than 80% of
patients in the United States (U.S.) (Gan, 2017). Patients that undergo surgical
procedures can suffer from harsh complications following the procedure. Even when
surgery is successful, patients suffer from pain postoperatively.
The number of surgeries being performed is at an all-time high and will continue
to increase as advances in medical technology allow surgeons to perform procedures they
never have before. Despite improved understanding of pain mechanisms, increased
awareness of the prevalence of postsurgical pain, advances in pain-management
approaches and inadequately controlled postoperative pain continues to be a problem
(Gan, 2017).
Postoperative pain is associated with many negative outcomes, both for the
patient and the hospital. The patient will suffer from prolonged recovery, immobility,
increased morbidity, and overall dissatisfaction with care (Gan, 2017). Both the patient
and the hospital will experience increased medical costs due to increased medication use
and a prolonged hospital stay. More importantly, poorly managed acute pain can result in
the development of chronic pain (Gan, 2017).
Many interventions are available for treating acute postoperative analgesia but
may fall short of fully eradicating it. A favorable management strategy for postoperative
pain is to address it pre-emptively, instead of waiting until the post-operative period.
Intra-operatively the anesthesia provider can administer a variety of medications that will
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greatly improve analgesia following surgery. One method is to use local anesthetics and
possible adjuvants to local anesthetics, such as dexmedetomidine. Garimella and Cellini
(2013) stated that intrathecal administration of a local anesthetic (0.5% bupivacaine) at
induction of anesthesia results in good postoperative analgesia for up to 24 hours. If an
adjuvant medication were to be added to the bupivacaine, that time could be even longer.
The use of adjuvant medications with local anesthetics to help improve
postoperative analgesia is a new intervention that is still being researched. Some
medications being used as adjuvants are dexamethasone, clonidine, and
dexmedetomidine. The benefit of these medications towards postoperative analgesia
needs to be considered, along with other effects they might pose. Overall, it is believed
the administration of these medications with local anesthetics will improve postoperative
analgesia. This is an important consideration for anesthesia providers, as it could make
an immense difference in postoperative analgesia and recovery.
Effectively treating pain leads to patient comfort, which allows for fewer
complications, early mobility, and early discharge. These positive outcomes not only
benefit the patient, but the hospital as well. Fewer complications and early discharge
result in decreased health costs for the facility. With thousands of surgeries being
performed daily, the need for controlled postoperative analgesia is essential.
Therefore, the purpose of this paper is to complete a systematic review to
determine if the administration of intrathecal dexmedetomidine, as an adjuvant
medication to bupivacaine, impacts postoperative pain in adult patients undergoing
surgery.
Next, the review of literature will be presented.
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Literature Review
A literature review was conducted using the databases CINAHL, Medline, and
PubMed. A combination of search terms were used to gather the appropriate research
articles. Those search terms were: adjuvant, postoperative pain, local anesthesia,
dexmedetomidine, dexamethasone, and clonidine. The search was limited to peer
reviewed articles and written in the English Language. There was no limit entered for
year published, but all the articles chosen were published between 2007-2018.
Definition and Pathophysiology of Pain
The International Association for the Study of Pain (IASP) defines pain as “an
unpleasant sensory and emotional experience associated with actual or potential tissue
damage, or described in terms of such damage” (Merksey, H., & Bogduk, N., 2012).
There are many different categories of pain, but for this review the focus is on
nociceptive pain. When there is damage to tissues, the body transmits a signal to the
brain. It does so by a process termed nociception, which is defined as the neural process
of encoding and transducing the noxious stimuli received by the body (Dubin &
Patapoutian, 2010). The presence of peripheral sensory neurons throughout the body
allows this process to occur. These specialized neurons are called nociceptors.
Nociceptors are found in the skin, bone, muscle, and joints. They are activated by
chemicals, such as Substance P or Glutamate, and are released when there is tissue
damage. This is the first phase of the pain pathway and is referred to as transduction.
The chemicals that are released excite the nociceptors, producing an action potential.
Dubin and Patapoutian (2010) defined action potential as an electric signal that is
propagated along nerves, enabling communication between neurons within the pain
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pathway. This electric signal travels to the dorsal horn of the spinal cord where it
synapses with secondary neurons and then travels to the thalamus within the brain. This
is the second phase of the pain pathway and is called transmission. Next, the process of
perception allows the body to become conscious of the noxious stimuli and allows
modulation of pain to take place. Modulation involves facilitatory and inhibitory
pathways in the spinal cord (Dubin & Patapoutian, 2010). This causes the release of
neurotransmitters that aim to inhibit nociception to free the body of pain, completing the
pain pathway.
In a descriptive study conducted by Rodriguez (2015), it is stated that pain elicits
protective reflexes such as an unconscious withdrawal from the noxious stimulus, muscle
spasms, and other autonomic reactions. This response occurs following the perception
and modulation of a pain signal. For example, if you were to burn your finger while
cooking dinner, the second your finger touched the hot pan nociceptors would respond to
the temperature and relay a signal through the neuronal axon up to the spinal cord, and
then to the brain causing you to withdraw your hand from the source of pain.
Pain is an ongoing problem that is dominating society. While there are many
causes of pain, acute postoperative pain is an evident issue existing in healthcare today.
Much research has been conducted on interventions to reduce postoperative pain but
postoperative pain is not adequately managed in greater than 80% of patients in the U.S.
(Gan, 2017).
Postoperative Pain
Management of postoperative pain is essential in the surgical patient. Pain causes
discomfort, which leads to many postoperative complications including pneumonia,
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mobility issues, constipation, and prolonged rehabilitation. Pain also increases the stress
response of the immune system, causing difficulties with healing (Banks, 2007). There
are many interventions used to treat postoperative pain. These interventions are key in
facilitating positive patient outcomes following surgical procedures. While there is no
defined best method of treating pain, heath care providers must consider that under
treatment of postoperative pain results in many negative effects, and it is crucial to be
informed of all current interventions to treat postoperative pain (Banks, 2007).
Recent evidence determined that 80% of patients who underwent surgical
procedures experienced acute postoperative pain, and less than half reported adequate
pain relief (Chou et al., 2016). This is an astounding statistic that led to the development
of new guidelines regarding management of postoperative pain control. In 2016, The
American Pain Society published 32 recommendations to promote effective management
of postoperative pain (Chou et al). These recommendations range from generalized to
specific. Within the new guidelines, the use of local anesthetics is highly recommended.
Chou et al. (2016) stated that local anesthetics have been shown to be effective as a
component of multi-modal analgesia for management of postoperative pain associated
with many surgical procedures; however, prior to treating pain, it must be understood
how to measure it.
Measuring Postoperative Pain. Earlier, this review addressed the
pathophysiology of pain, including perception of pain. As stated before, it is when the
brain interprets and processes a pain signal. This is a subjective phenomenon that can
vary between individuals. A surgery that causes considerable pain for one person could
cause no pain at all for someone else due to the processing of pain signals in the brain.
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This poses a problem; how do we measure pain if it is perceived differently in each
patient? The subjective nature of pain makes its reliable measurement by health
professionals a key factor in its successful management (Coll, Ameen, & Mead, 2004). A
thorough nurse assessment coupled with pain measurement scales is the current standard
for addressing postoperative pain.
There are a multitude of scales available to assist with measuring postoperative
pain. Among the most commonly used are the Visual Analog Scale (VAS) and the
Numerical Rating Scale (NRS). It is important to understand how these scales work to
adequately interpret research results regarding postoperative pain. While both scales
focus on the patient’s perception of pain, they do so in different manners.
The VAS consists of a 100-millimeter line, usually horizontal, with the ends of
the lines representing extremes of pain interpretation. The left side represents ‘no pain’
and the opposite end represents ‘unbearable pain’ (Coll et al., 2004). The patient is asked
to point or make a mark on the line where their pain level falls. That point is then
measured how far away from the left (lower) side of the line it is in millimeters. The
larger the distance the more intense the pain. Once the distance is determined, the pain
can be treated appropriately.
The NRS measures pain similarly. Its original form consisted of a horizontal line,
in which one end is labeled 0 and the other end labeled 10; the patient is asked to pick a
point along the line, from 0-10, to identify the intensity of their pain (Coll et al., 2004).
Since its original development different versions of this scale have been produced but the
generality of rating pain from 0-10 is one of the most commonly used approaches today
(Coll et al., 2004).

7

Validity of the VAS and NRS. Valid and reliable pain assessment tools are
essential in the management and treatment of postoperative pain. Medical professionals
use pain scales to guide treatment plans. If the scales are unreliable, the treatment plan
will be inadequate. Studies have been conducted to assess validity and reliability of the
different pain scales. A systematic review by Hjermstad et al. (2011) examined the use
and performance of unidimensional pain scales, including the VAS and the NRS, in
cancer patients. Hjermstad et al. (2011) found that both the VAS and NRS work well,
and the most important choice is not the type of scale, but the conditions related to its
use. It is necessary to choose the scale based on the patient’s level of cognitive
functioning. Although the VAS was the most frequently used pain scale, it was found
that the NRS suited some patients better. For example, Hjermstad et al. (2011) reported
that the NRS was superior in 11 studies due to ease of use and high compliance, while
lower compliance was found with the VAS in patients associated with higher age, degree
of trauma, or other impairments. Thus, it can be assumed the scale is better utilized when
patient specific factors are considered, but the subjectivity of pain makes it necessary to
assess pain perception in a standardized fashion. Hjermstad et al. (2011) found that both
the NRS and the VAS work well in comparison, so either tool is acceptable.
Once a measurement technique is determined, the provider can determine what
the best plan for treatment is. There are many approaches to treating postoperative pain,
but this review will focus on local anesthetics.
Local Anesthetics and Their Role in Pain Control
Local anesthetics contain a group of medications that work by inhibiting sensory,
motor, and autonomic nerve function (Butterworth, Mackey, & Wasnick, 2013). These
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are medications classified as esters or amides that block nerve function, using the nerve
roots as the site of action. Normally, activation of sodium channels causes an influx of
sodium ions, generating an action potential (Butterworth et al., 2013). Local anesthetics
diffuse into the cell where they bind to sodium channels, blocking them. This prevents
depolarization, which inhibits any action potentials from being spread. By preventing the
action potential, sensation in that area is decreased or completely hindered. Local
anesthetics are commonly used alone in surgical procedures but can be combined with
other medications to improve analgesic outcomes. The main local anesthetics used in
practice today are bupivacaine, ropivacaine, levobupivacaine, and hyperbaric
bupivacaine.
Bupivacaine. Bupivacaine is the preferred local anesthetic in caudal, epidural,
and spinal anesthesia and is used to manage acute and chronic pain (Paganelli & Popescu,
2015). In addition to blocking sodium channels intracellularly, bupivacaine has been
thought to have inhibitory effects on the N-Methyl-D-aspartic acid (NMDA) receptor.
Inhibition of the NMDA receptor is an effective strategy in prevention and management
of chronic pain syndromes (Paganelli & Popescu, 2015).
Bupivacaine is considered a long acting local anesthetic with a duration time of
four to eight hours (Paganelli & Popescu, 2015). Bupivacaine is also known for its high
level of sensory anesthesia and can be administered locally in the skin or regionally into
the spine, which is referred to as intrathecal administration. Intrathecal administration
consists of injecting the medication directly into the spinal column and into the
cerebrospinal fluid. Injecting the medication into the spine allows for regional
anesthesia, which blocks sensation in an area of the body.
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Adjuvants to Local Anesthetics to Improve Postoperative Pain
The use of adjuvants with local anesthetics has been practiced for several years
now but continues to be a relevant subject of interest (Wiles & Nathanson, 2010). While
local anesthetics have satisfactory effects, there continues to be an ongoing search for
medications with longer duration of action, better nerve selectivity, less degree of motor
block, and a lower occurrence of systemic toxicity (Wiles & Nathanson, 2010). The use
of adjuvant medications along with local anesthetics aims to provide these outcomes.
With the ability to prolong local anesthetic blockade, specifically sensory block, there
would be a drastic decrease in postoperative pain levels. There are several medications
that have been trialed for adjuvants to local anesthetics including clonidine and
dexamethasone. These medications will be discussed briefly in this literature review, but
the focus is on dexmedetomidine as an adjuvant and will be discussed in more depth.
Clonidine as an adjuvant to local anesthetic. Clonidine is a selective 2
adrenergic agonist and works by decreasing peripheral vascular resistance. As a result
blood vessels relax, allowing decreased blood pressure and heart rate. A prospective,
randomized, controlled trial (RCT) by Chakraborty, Chakrabarti, Mandal, Hazra, and Das
(2010), compared the effect of low dose clonidine versus placebo as an adjuvant to
bupivacaine. Quantitative data was collected through an experimental, double blinded
study approach. The sample included 70 participants, ages 18-60, and participants were
randomly allocated into one of two groups. Group A received bupivacaine with
clonidine, while Group B received bupivacaine with normal saline. Chakraborty et al.
(2010) found a significant difference of approximately 221 minutes from the time group
A needed analgesia medication to the time Group B needed to be medicated (p < 0.001).
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This study suggested that low dose clonidine as an adjuvant to bupivacaine prolonged the
duration of analgesia.
Gorniak, Proost, Veckeneer, Mulder, and Wubbels, (2014) conducted a
prospective RCT, which aimed to determine the effect of clonidine as an adjuvant to
levobupivacaine on postoperative analgesia. The study included 120 participants
randomly assigned to two groups. Group one received only levobupivacaine while group
two received levobupivacaine with clonidine. Data was collected by a patient selfreported questionnaire, and only 101 participants completed and returned the
questionnaire. The participants were asked to rate post-operative pain using the VAS
ranging from 0-10, and 10 being the worst pain imaginable (Gorniak et al., 2014).
Gorniak et al. (2014) found that the use of clonidine as an adjuvant to local anesthesia is
limited in terms of benefits and reducing post-op pain. Participants who reported pain
compared to those who did not report pain in the control group were 18:34, and 18:31 in
the clonidine group. Hence, there was not a significant difference between the two
groups.
Dexamethasone as an adjuvant to local anesthetics. Dexamethasone is a
corticosteroid; a class of medications that aid primarily in reducing inflammation.
Desmet et al. (2013) conducted a prospective, randomized, placebo-controlled study in
which researchers hypothesized that intravenous (IV) and perineural (around nerves)
dexamethasone have an equal effect of prolonging analgesia when used with the local
anesthetic nerve block ropivacaine. A sample size of 150 participants was allocated
randomly into one of three groups. Group one received ropivacaine only, group two
received ropivacaine with perineural dexamethasone 10 mg, and group three received IV
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dexamethasone 10 mg only. Data was collected by the NRS, on a scale of 0-4 with 4
being severe pain. Researchers found dexamethasone significantly prolonged the
duration of analgesia (p < 0.001). The results strongly supported the researcher’s
hypothesis.
Desmet et al. (2015) conducted a second RCT in which dexamethasone was
combined with a local anesthetic for shoulder surgery. The researchers hypothesized that
different doses of dexamethasone would prolong analgesic duration of the local
anesthetic block. The study was a prospective, placebo-controlled, randomized trial that
allocated 240 participants into four separate groups, 60 in each group. Participants either
received IV saline 0.9%, or a dose of dexamethasone 1.25mg, 2.5mg, or 10mg during
surgery. All were adjuvants to the local anesthetic ropivacaine. Data was collected by
patient self-report, and participants would rate their pain as none, mild, moderate, or
severe. Researchers found that IV dexamethasone prolongs the duration of postoperative
analgesia with a greater effect at a dose of 10mg than 2.5mg (Desmet et al., 2015). No
statistical difference was noted between dexamethasone doses of 2.5mg versus 10mg.
Generally, when dexamethasone was used with ropivacaine analgesia was prolonged, as
opposed to when ropivacaine was used with normal saline. The results supported the
researcher’s hypothesis.
Dexmedetomidine as an Adjuvant to Local Anesthetics. Dexmedetomidine is
a selective alpha-2 agonist approved for sedation but has more recently been investigated
for its analgesic effects. It has an effect on the body both peripherally and centrally.
Peripherally, it decreases the release of norepinephrine causing inhibition of nerve action
potentials (Nazir & Jain, 2016). Centrally, it causes inhibition of the release of substance

12

P at the level of the dorsal root neuron resulting in analgesia (Nazir & Jain, 2016). More
specifically, it has been used intrathecally as an adjuvant to spinal anesthesia to assist in
prolonging efficacy of both medications (Das et al., 2015).
Das et al. (2015) conducted a prospective, double blind, randomized controlled
study and compared two different doses of dexmedetomidine added to bupivacaine on
duration of analgesia. The sample consisted of 100 participants scheduled to have an
abdominal hysterectomy under spinal anesthesia. The participants were allocated using a
computer-generated random number list into two different groups. Participants either
received 5 mcg or 10 mcg of dexmedetomidine. Both doses of dexmedetomidine were
administered along with 15mg of bupivacaine. The anesthetic technique was
standardized for each participant, and the intervention was applied exactly as stated,
assuring intervention fidelity. Data was collected postoperatively by patients’ self-report
of pain based on the VAS. After analyzing the data, researchers found that spinal
dexmedetomidine increased the time before first analgesic use was required, and it also
decreased analgesic consumption. The group that received the 10 mcg waited longer
before taking the first dose of analgesic medications than the group that received only
5 mcg (P<0.05), and also required less breakthrough pain medication overall (Das et al.,
2015). The evidence supported the author’s hypothesis.
A study was conducted by Nazir and Jain (2016) that aimed to compare the
postoperative analgesic effects of dexmedetomidine for brachial plexus blockade along
with bupivacaine. A brachial plexus blockade is when a local anesthetic is injected
during surgery on the upper extremity. This was a prospective, randomized, controlled
trial that consisted of 70 participants. Participants were allocated into two separate
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groups. Participants in the control group received bupivacaine with normal saline and
participants in the experimental group received bupivacaine with dexmedetomidine.
Data was collected postoperatively by patients’ self-report of pain using a NRS of 1-10,
10 being the worst pain. At a score of 4, rescue analgesic was administered. The
researchers assessed how long it took for the first dose of rescue analgesic to be
administered. After analyzing the data researchers found the time to first analgesia was
significantly prolonged in the experimental compared to the control group (p < 0.0001).
Nazir and Jain (2016) concluded that dexmedetomidine is an effective adjuvant to
bupivacaine.
Next, the theoretical framework utilized for this systematic review will be
presented.
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Theoretical Framework
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement was designed to assist in the quality of reporting of controlled trials.
A systematic review is an analysis of a relevant research question that uses systematic
methods to identify, select, and appraise relevant research (Moher, Liberati, Tetzlaff,
Altman, & PRISMA Group, 2009). In a meta-analysis, statistical data is used to analyze
and summarize the results. Systematic reviews and meta-analyses serve a significant
purpose in healthcare. The results of various studies can be reviewed and summarized so
relevant information can be extracted and reported. Writing a systematic review can be a
complex and challenging task, therefore the PRISMA statement was developed to assist
and improve the process of reporting.
The PRISMA statement evolved from the Quality of Reporting of Meta-analyses
(QUOROM) statement in 2005. QUOROM is a guideline for appraising meta-analyses.
The goal of expansions was to include systematic reviews as well. The PRISMA
statement consists of a 27-item checklist and a flow diagram with four phases (Moher et
al., 2009). The PRISMA checklist (Appendix A) guides you through a series of steps to
assist with evaluation of a study. The steps are grouped into seven sections: title,
abstract, introduction, methods, results, discussion, and funding. Each section is further
divided into topics. This checklist will be utilized by the author to assure completeness
of the systematic review.
The PRISMA statement also contains a flow diagram (Appendix B) that is a
model used for depicting phases of a systematic review. It depicts the stages of
identification, screening, eligibility, and studies included.
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All research is valuable to clinical practice and the importance of that research
relies on what was done, what was found, and the clarity of information (Moher et al.,
2009). The PRISMA statement was utilized by the author during production of the
systematic review.
The CASP checklist (Appendix C) was also utilized to critically appraise the data.
This tool proposes a systematic process to assist with identifying strengths and
weaknesses of a research study (Singh, 2013). The CASP tool has several checklists,
each for a specific type of research study. The checklist designed for a systematic review
was utilized for this paper and will be described further in the methods section.
The methods of this systematic review will be discussed next.
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Methods
Purpose
The purpose of this paper is to complete a systematic review to determine if the
administration of intrathecal dexmedetomidine, as an adjuvant medication to
bupivacaine, impacts postoperative pain in adult patients undergoing surgery.
The research question to be examined in this review is: Does the administration of
intrathecal dexmedetomidine, as an adjuvant medication to bupivacaine, decrease time to
first analgesia, in postoperative adult patients?
Inclusion and Exclusion Criteria
Inclusion criteria consisted of randomized controlled trials published in the last
ten years, written in the English language, participants 18 years or older and undergoing a
surgical procedure in which dexmedetomidine was used as an adjunctive to intrathecal
bupivacaine. Exclusion criteria included participants younger than 18 years old, articles
that used adjuvant medications other than dexmedetomidine, and articles that used local
anesthetics other than intrathecal bupivacaine.
Search Strategy
The PRISMA checklist and flow diagram were used to guide the search strategy.
Research was collected using the databases CINAHL, Medline, and PubMed. The search
terms used were: dexmedetomidine, postoperative pain, and intrathecal bupivacaine. The
articles were screened for inclusion and exclusion criteria. Studies were chosen based on
the title, the abstract and whether it correlated with the purpose of this paper which was
to complete a systematic review to determine if the administration of intrathecal
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dexmedetomidine, as an adjuvant medication to bupivacaine, impacts postoperative pain
in adult patients undergoing surgery.
Data Collection and Synthesis
Each article was carefully read and pertinent information was extracted. Data was
entered into two tables created by the author of this systematic review. The data tables
summarize information that is easily interpretable. Data collected and displayed in Table
1 include purpose, setting, sample size, and design method. Data collected and displayed
in Table 2 include procedure, pain scale used, results, and limitations of the study.
Table 1.
Data Collection Tool 1
Purpose

Setting

Sample Design Method

Table 2.
Data Collection Tool 2
Procedure

Pain Scale Used

Results

Limitations

Critical Appraisal Tool
The CASP checklist was used to guide the critical appraisal of selected articles. It
consists of three sections, totaling eleven questions that are used to guide the review
process.
Section A asks if the results are valid. This section starts with two questions that
are referred to as screening questions, which can be answered quickly and easily but must
be addressed before moving on. Once it is determined the results are valid, the next
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section addresses what the results are. Section B asks two questions: What are the overall
results of the review, and the second asks how precise the results are. Lastly, Section C
addresses whether the results will be helpful locally and whether the results are feasible.
Prompts are given throughout the three sections to facilitate answering the questions.
The CASP tool was used to systematically evaluate each article and its results.
The guidelines are clear and concise, making it easy to understand. The questions are
wide ranging and offer direction, facilitating a structured approach to analyzing evidence
(Singh, 2013).
Cross Analysis
A cross study analysis was performed that compared the effects of
dexmedetomidine to the time of first analgesic request postoperatively as well as type of
procedure, pain measurement tool, and dosage of medications used in each study. A
table was formulated to compare the results of the control group compared to the
intervention group across studies (Table 3). The similarities and differences between the
studies will be compared.
Table 3.
Cross Study Analysis
Authors

Procedure/Type Pain
of surgery
Measurement
Tool

Next, the results will be discussed.

Dosage
Used

Control
Groupmean time
to first
analgesic
request
(minutes)

Intervention
Group- mean
time to first
analgesic
request
(minutes)
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Results
Data Collection
The PRISMA flow diagram was utilized to guide the search for pertinent
literature. Multiple databases were used to identify pertinent records, and duplicates were
excluded. An initial broad search was performed using the term “dexmedetomidine”.
Search results showed 1,287 results through CINAHL, 4,214 through PubMed, and 4,510
through Medline. The search was then narrowed by applying the secondary term
“postoperative pain”. Results from CINAHL, PubMed, and Medline dropped to 165,
233, and 549 respectively. The search was narrowed once more by adding the term
“bupivacaine”. CINAHL, PubMed, and Medline results dropped further to 27, 36, and 75
respectively. The records were then screened for availability of full text, and further
screened for inclusion and exclusion criteria. After eligibility of articles was determined,
the number of RCTs were totaled and accounted for. Six RCTs were chosen for review
(Figure 1).
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Figure 1. PRISMA Flow Diagram
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An RCT by Kim, Kim, Lee, and Kil (2013) assessed 54 elderly patients
undergoing transurethral resection of the prostate (TURP) under a spinal anesthetic using
low dose bupivacaine. The authors calculated a sample size of 23 patients in each group
would be required to achieve power of 80% and a significance level of 0.05. A random
allocation sequence was used to assign groups: the experimental group received spinal
dexmedetomidine in addition to bupivacaine and the control received only bupivacaine.
A spinal puncture was performed with the patient in the lateral decubitus position at the
3rd-4th or 4th-5th interbody lumbar space with a midline approach using a 25-gauge
Quincke needle. After confirmation of CSF flow the pre-prepared drug was administered
and the patient was placed in the supine position. Those in the experimental group
received 3 micrograms (mcg) of dexmedetomidine combined with 6 milligrams (mg) of
hyperbaric bupivacaine, while the control group received 6 mg of bupivacaine with 3
mcg of saline. Following the procedure, the patient was brought to the post-anesthesia
recovery unit (PACU) where the time until first analgesic request was recorded. Pain
levels were assessed using the VAS at 30 minutes post-operatively, and again at 6 hours,
24 hours, and 36 hours after discharge. The authors found the number of patients
requiring postoperative analgesics was similar between the two groups, but the
dexmedetomidine group had fewer overall requirements for rescue analgesic medications
with a p value <0.01. The mean time to first analgesic request in the control group was
345 minutes, compared to the experimental group, which was 1360 minutes. Kim et al.
(2013) also reported that time to first analgesic was longer in the dexmedetomidine
group, p =0.039 (Appendix D).
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Abdelhamid and El-lakany (2013) assessed 62 patients presenting for inguinal
hernia repair over a three-month period. Patients were ages 18-60 years old. Patients
were randomized into one of two groups using the sealed envelope technique. One group
received 3.5 ml of bupivacaine with 5 mcg of dexmedetomidine, and the other group
received 3.5 ml of bupivacaine with normal saline. A 25-gauge pencil point needle was
inserted through the 4th-5th interbody lumbar space and medication was injected over 10
seconds. Postoperatively, the amount of time until first analgesic request was recorded.
Total analgesic consumption over 24 hours was also recorded. No pain scale was used.
The authors found that analgesic requirements were significantly lower in the group that
received the bupivacaine and dexmedetomidine and reported a p value of <0.0001. Total
analgesic consumption was also lower in the group that received bupivacaine with normal
saline (p value of <0.0001). The mean time until first analgesic request was 259 minutes
in the group that did not receive dexmedetomidine, compared to 381 minutes in the group
that did receive the dexmedetomidine (Appendix E).
Bi, Cui, Zhang, Song, and Zhang (2017) assessed 60 patients presenting for
elective cesarean section undergoing spinal anesthesia. Patients were of ASA status 1 or
2, ages ranged from 18-40. Patients were randomized into one of three groups using a
computer-generated randomization table. One group received 10 mg of bupivacaine
alone, the second group received 10 mg of bupivacaine with 3 mcg of dexmedetomidine,
and the third group received 10 mg of bupivacaine with 5 mcg of dexmedetomidine.
Lumbar epidural anesthesia was induced using a 25-gauge pencil point needle. The drugs
were injected at a rate of 1ml/15 seconds, and each spinal was administered by the same
anesthesiologist. Postoperative pain was assessed using the VAS at 6 and 12 hours after
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surgery. The time to first rescue analgesic was also recorded. The authors found that
pain ratings at 6 hours were higher in the group that received bupivacaine alone (p value
= 0.0032). There was no difference between the groups at 12 hours (p=0.3533).
Additionally, the time to first rescue analgesic was not significantly different (p=0.7096).
The mean time to first request for analgesia was 1320 minutes in the group that received
no dexmedetomidine, compared to 1488 minutes and 1428 minutes in the groups that
received 3mcg and 5mcg of dexmedetomidine respectively (Appendix G).
Patro, Deshmukh, Ramani, and Das (2016) conducted a study of 60 patients
undergoing infra-umbilical surgery with spinal anesthesia. The types of infra-umbilical
surgeries included in the study were hysterectomies, hernia repairs, appendectomies, and
open urosurgical procedures. Participants were ages 18-45 and ASA status 1 or 2. Data
was collected over a two-month period. The participants were randomly allocated into
two groups using the sealed envelope technique. Group one received 3ml of 0.5%
hyperbaric bupivacaine with 0.5ml of normal saline. Group two received 3ml of 0.5%
hyperbaric bupivacaine with 5mcg of dexmedetomidine. The medication was prepared
by an anesthesiologist not involved in the study. Lumbar puncture was performed with
the patient in left lateral decubitus position with a 25-gauge needle inserted at the L3-L4
intervertebral space. VAS was recorded postoperatively at three, six, and twelve hours.
Rescue analgesics were administered when VAS was greater than three. The cutoff point
for the study was when the patient required the first dose of rescue analgesia. The
authors found a significant difference in duration of analgesia between the two groups.
After three hours, the mean VAS in group one was 1.03 and 0.03 in group two. At six
hours, the mean VAS in group two was 2.67 and 3.7 in group one (p < 0.001). The mean
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time until first analgesic request postoperatively was 269 minutes in group one and 399
minutes in group two.
Salem, Darweesh, Wanis, and Mohamed (2015) assessed 52 patients undergoing
posterolateral lumbar spinal fusion with intrathecal anesthesia. Participants were ages
40-65 years old and ASA status 1 or 2. Participants were separated into one of two
groups using the sequentially numbered closed envelopes. Group one received 15mg of
hyperbaric bupivacaine with 5mcg of dexmedetomidine. Group two received 15mg of
hyperbaric bupivacaine with 0.5ml of saline. Lumbar puncture was performed in sitting
position at the level of L3-L4 intervertebral disc space. A 25-gauge needle was used, and
the same anesthesiologist performed all spinals. Also, the same surgeon performed all
surgeries. Postoperatively, the total dose of analgesic medication over 24 hours was
recorded. The authors found that time to first analgesic request was significantly longer
in group one ( p <0.0001). Salem et al. (2015) also found the total dose of analgesic
medication over 24 hours was smaller in group one (p < 0.0001). The mean time until
first analgesic request was 399 minutes in group one, compared to 269 minutes in group
two (Appendix H).
Yetkas and Belli (2014) assessed 60 male patients undergoing inguinal surgery
under spinal anesthesia. Participants were between the ages of 20-30 years old. Patients
were divided randomly into three groups. Group one received 15mg of hyperbaric
bupivacaine with 0.5ml of normal saline; group two received 15mg of hyperbaric
bupivacaine with 2mcg of dexmedetomidine; and group 3 received 15mg of hyperbaric
bupivacaine with 4mcg of dexmedetomidine. Lumbar puncture was performed with the
patient in a sitting position. A 25-gauge spinal needle was inserted into the L4-L5 disc
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space, and when CSF flow was observed the pre-prepared medical solution was injected.
Postoperatively the time until onset of pain was recorded, as well as the total amount of
analgesic medication administered over 24 hours. The authors found that time until
initiation of pain was significantly longer in group three than in groups one and two (p <
0.001). They also found that analgesic medication consumption over 24 hours was
significantly higher in group one than in groups two and three (p < 0.001). The mean
time until first analgesic request was 220 minutes in group one, 371 minutes in group
two, and 1042 minutes in group three (Appendix F).
Critical Appraisal
The six randomized control trials discussed in this paper were critically appraised
using CASP.
In the study by Kim et al. (2013) a total of 54 elderly patients were randomized
into one of two groups to evaluate the adjuvant effects of intrathecal dexmedetomidine
with bupivacaine on postoperative pain. All the critical analysis questions were scored
“yes” except one question that asked if groups were similar at the start of the trial.
Patients underwent the same surgery and 39 out of 54 participants had more than one
systemic disease, but these systemic diseases were not further distinguished between the
two groups. It was unclear if the two groups were similar at the start of the study. The
patients, healthcare workers, and study personnel were all blinded to the treatment. All
participants were treated equally throughout the study (Appendix J).
In the Abdelhamid and El-lakany (2013) study, all participants were randomly
divided into two groups using the sealed envelope technique. Most critical appraisal
questions were answered “yes” except for two. One asked if groups were similar at the
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start of the trial. Participant ages varied significantly, between 22-56 years old, and the
distribution between groups was unclear. Second, all clinically important outcomes were
not considered. Immediate outcomes were considered, but nothing beyond the immediate
post-operative period was assessed. There was no documented follow up with any of the
participants. Participants, healthcare workers, and study personnel were all blinded to the
treatment. Groups were treated equally throughout the study (Appendix K).
In the study by Bi et al. (2017) all critical appraisal questions were scored “yes”
except for one that asked if all the participants who entered the trial were accounted for at
its conclusion. During the study if spinal anesthesia failed, participants would be
excluded. The authors did not identify how many spinals failed, and they did not specify
how many participants finished the study. All personnel involved with the study were
blinded and the groups were treated equally. All clinically important outcomes were
considered (Appendix L).
In the study by Patro et al. (2016) all critical appraisal questions were scored
“yes”. Participants, healthcare workers, and study personnel were blinded to the
treatment. Both groups were treated equally, and all important clinical outcomes were
considered (Appendix M).
In Salem et al.’s (2015) study, a total of 52 participants were randomized and
enrolled into one of the two groups. All personnel involved with the study were blinded
to the treatment. Groups were similar at the start of the study. Although, it was unclear
if the groups were treated equally; no information was provided by the authors. All
clinically important outcomes were considered and no adverse outcomes were noted in
the intervention group (Appendix N).
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In the study by Yetkas and Belli (2014), a total of 60 participants were
randomized and enrolled into one of the three groups. All critical appraisal questions
were scored “yes” except for one that asked if the benefits were worth the harm and cost.
This study found clear benefits of using dexmedetomidine with hyperbaric bupivacaine
intrathecally with no additional harm to the patient; however, no cost analysis was
addressed. All participants, healthcare workers, and study personnel were blinded to the
treatment. Groups were similar at the start and treated equally throughout the study
(Appendix O).
Cross Analysis
The randomized control trials of this systematic review were analyzed across
studies (Appendix P). The cross analysis compared the effects of dexmedetomidine to
the time of first analgesic request postoperatively as well as dose of dexmedetomidine
used, type of surgery, and pain scale used.
All randomized control trials included in this systematic review investigated
different surgeries. The anesthesia provided for the surgery was the same (spinal
anesthesia) but surgical procedures varied. Kim et al. (2013) investigated patients
undergoing transurethral prostatectomy; Abdelhamid and El-lakany (2013) investigated
lower abdominal surgeries; Yektas and Belli (2014) investigated inguinal surgeries; Bi et
al. (2017) investigated cesarean section; Salem et al. (2015) investigated posterolateral
lumbar spinal surgeries and; Patro et al. (2016) investigated infraumbilical surgeries. All
studies reported improved postoperative pain in the intervention groups. Even though the
surgeries being performed were different in each study, the results supported the
hypothesis that intrathecal dexmedetomidine would improve postoperative pain.
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Another aspect of each study that was analyzed was the type of pain scale used.
Three of the randomized control trials used the VAS, one used the numerical rating scale,
and two used no scale at all, instead measuring time in minutes to first analgesic request.
As stated earlier, these different methods of evaluating pain are all reliable. Results were
similar across all studies, regardless of the type of scale used.
Another aspect compared across studies was time to first analgesic request in the
control group versus intervention group. All the randomized control trials in this
systematic review reported improved postoperative pain when dexmedetomidine was
added to intrathecal bupivacaine. This was shown clearly in the cross-analysis table,
represented by longer mean time until first analgesic request. The longer it took for
patients to request pain medication in the postoperative period, the longer intrathecal pain
relief lasted. The most significant results were found in the study by Kim et. al (2013).
Mean time to first analgesic request in the control group was 345 minutes, and in the
intervention group it was 1360 minutes. These results showed a significant difference
between the two groups (p=0.006).
The last aspect compared across studies was the dosage of dexmedetomidine
used. The dosages of dexmedetomidine across studies ranged from 2-5 mcg. All doses
were associated with decreased postoperative pain, but the study by Kim et al. (2013) had
the most significant results. This trial used a dose of 3mcg of dexmedetomidine. This
was not the highest dose used, yet it yielded the most significant results. This proposes
that even lower dosages of the medication can have profound effects in decreasing
postoperative pain levels and a higher dose may not be necessary.
Next, the summary and conclusions section will be presented.
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Summary and Conclusions
Postoperative pain continues to be a substantial issue in the healthcare field. As
stated earlier, it is inadequately managed in the majority of patients. Postoperative pain
directly correlates with negative patient outcomes and increased hospital costs.
Traditional management of postoperative pain consists of parenteral opioids, which are
associated with numerous adverse side effects (Banks, 2007). The nurse anesthetist
should utilize all modalities of pain relief throughout surgery to improve postoperative
pain. One method is to use local anesthetics and adjuvants to local anesthetics, such as
dexmedetomidine.
Local anesthetics may be used in a variety of clinical settings for treating mild to
severe pain (Banks, 2007). Furthermore, the addition of dexmedetomidine to local
anesthetics can make an immense difference in postoperative analgesia and recovery.
The purpose of this paper was to complete a systematic review to determine if the
administration of intrathecal dexmedetomidine, as an adjuvant medication to
bupivacaine, impacts postoperative pain in adult patients undergoing surgery.
A literature review was conducted utilizing inclusion and exclusion criteria
generated by the author. The databases CINAHL, Medline, and PubMed were utilized
for the search. The PRISMA flowchart was used to guide the search strategy. A total of
six randomized control trials were selected for inclusion. Each article was carefully read
and pertinent information was extracted. Data collection tables were formulated for all
articles. Information collected from each article included purpose, setting, sample,
design method, procedure, pain scale used, results, and limitations. Following data
collection, a critical appraisal was performed on the selected articles. The CASP
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checklist was used to guide the critical appraisal. Analysis across studies focused on the
type of surgery, the pain scale used, and mean time to first analgesic request for control
and intervention group.
All six randomized control trials in this systematic review reported improved
postoperative pain when dexmedetomidine was added to intrathecal bupivacaine. Overall
analgesia requirements were lower in all intervention groups. The most significant
results were found in the study by Kim et al (2013). These results showed a significant
difference between the two groups (p=0.006). Time to the first requirement of analgesia
was significantly longer in the intervention group.
After thorough evaluation of the literature, limitations to this systematic review
were identified. The primary limitation to this systematic review was that each control
trial evaluated different surgical techniques. The argument could be made that variations
in surgical procedures have different expectations for postoperative pain, therefore the
results may not be generalized across procedures. While the results were the same for
each trial, a stronger correlation could have been made if the surgical procedures were the
same across all studies. Another limitation was the fact that different doses of
dexmedetomidine were used in several of the RCTs. The use of dexmedetomidine
showed improved postoperative pain, but the ideal does needs to be further investigated.
In addition to these limitations, ages of the study populations also varied. All participants
across studies were healthy, ASA status 1 or 2, but ages varied greatly. Between all six
studies, ages varied from 18 to 65. Participants of similar age groups may have made the
results more generalizable. Although these limitations existed, the purpose of this
systematic review was achieved.
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Despite limitations, this systematic review provides evidence that intrathecal
dexmedetomidine as an adjuvant to bupivacaine will improve postoperative pain.
Next, recommendations and implications for advanced practice nursing will be discussed.
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Recommendations and Implications for Advanced Nursing Practice
Management of postoperative pain is an important aspect of care for every
surgical patient. Certified Registered Nurse Anesthetists (CRNAs) play an integral role
in the management of postoperative pain. Adequate pain control is a crucial component
of patient recovery. Pain can diminish a patient’s ability to participate in postoperative
interventions such as coughing, deep breathing, and ambulating (Francis & Fitzpatrick,
2012). All these interventions can facilitate a fast, un-complicated recovery and improve
patient outcomes.
There are many methods used to treat postoperative pain. These methods are key
in facilitating positive patient outcomes following surgical procedures. There is no
consensus on the best method for controlling pain, but health care providers must stay
abreast of current methods used for postoperative pain management (Banks, 2017). One
method to control postoperative pain is administration of spinal anesthesia. This method
is regularly used by CRNAs for a variety of surgical procedures. There are standard
medications recommended for use intrathecally, including bupivacaine. Of recent years,
there has been increased use of adjuvant medications used intrathecally. One of these
adjuvant medications is dexmedetomidine.
This systematic review researched the most current evidence regarding the use of
dexmedetomidine as an adjuvant to intrathecal bupivacaine. The review provides
evidence that intrathecal dexmedetomidine, as an adjuvant to bupivacaine, will improve
postoperative pain. Applying this evidence to practice is the next step. Anesthesia
providers need to be educated on the valuable effects of this intervention. Once
education has taken place, the intervention can be applied at the clinical level. Once the
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intervention is applied, patients should be evaluated in the postoperative period for both
positive and negative effects of intrathecal dexmedetomidine. This change in practice
would be a simple one to implement if adequate education was provided to the anesthesia
care team.
It is important that CRNA practice is evidence-based. For years, systematic
reviews have been utilized by Advanced Practice Nurses to formulate guidelines of care.
This systematic review could aid in future research regarding improved management of
postoperative pain.
The use of dexmedetomidine as an adjuvant to intrathecal bupivacaine has been
proposed, but further research and education needs to be provided on the topic. Further
research about the dose of dexmedetomidine would be beneficial. All trials proposed in
this review used slightly different doses of dexmedetomidine, and all addressed the need
for further research on the matter. Identifying a specific dose could improve guidelines
for easier implementation.
Future recommendations include the addition of adjuvant medications to local
anesthetics intraoperatively. Published studies have supported the hypothesis that
dexmedetomidine as an adjuvant medication to intrathecal bupivacaine will improve
postoperative pain. Although more research on the dose of dexmedetomidine is required,
benefits of the intervention have been supported.
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Appendix A

(Moher et al., 2009)
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Appendix B

Identification

PRISMA 2009 Flow Diagram

Records identified through
database searching
(n = )

Additional records identified
through other sources
(n = )

Eligibility

Screening

Records after duplicates removed
(n = )

Records screened
(n = )

Records excluded
(n = )

Full-text articles assessed
for eligibility
(n = )

Full-text articles excluded,
with reasons
(n = )

Included

Studies included in
qualitative synthesis
(n = )

(Moher et al., 2009)

Studies included in
quantitative synthesis
(meta-analysis)
(n = )
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Appendix C

(CASP, 2018)
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Appendix D
Table 1
Kim, J.E., Kim, N.Y., Lee, H.S., & Kil, H.K. (2013). Effects of intrathecal
dexmedetomidine on low-dose bupivacaine spinal anesthesia in elderly patients
undergoing transurethral prostatectomy. The Pharmaceutical Society of Japan,
36(6), 959-965.
Purpose

Setting

Sample

Design Method

-Evaluate adjuvant
effects of intrathecal
dexmedetomidine in
elderly patients
undergoing TURP
surgery with low dose
bupivacaine spinal
anesthesia
-Primary end-point:
time to regression of 2sensory dermatomes
from peak sensory
block level
-Secondary end-points:
motor block scales at
peak sensory block and
postoperative analgesic
requirement

-Approved by
the Institutional
Ethics
Committee of
Yonsei
University
Health System of
Japan
-Conducted at
one hospital

-54 elderly
patients, ages 6074
-Patient
characteristics
were similar;
39/54 had more
than one systemic
disease
-All patients
completed study

-Participants
randomized into
one of two groups:
a group that
received 3mcg of
dexmedetomidine
combined with
6mg of hyperbaric
bupivacaine, and
another group that
received the same
amount of NS and
bupivacaine
-A random number
sequence was used
-In the PACU, the
time to first
analgesic request
was recorded

Table 2
Procedure

Pain Scale Used/

Results

Limitations
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TURP surgery.
Spinal puncture
was performed at
L3-4 or L4-5 with
a midline
approach using a
25G Quincke
needle in the
lateral decubitus
position. After
confirmation of
free flow and
clear
cerebrospinal
fluid, the drug
was administered,
and patient was
placed in the
supine position.

-VAS
-assessed pain
level: arrival to
PACU, 30 minutes
after arrival, and
then 6h, 24h, and
36h after discharge.
-Time to first
analgesic request
was recorded.

Number of
patients requiring
postoperative
analgesics
weren’t different
between the two
groups, but
dexmedetomidine
group had less
requirements for
postoperative
rescue analgesics
(p < 0.01)
-Time to request
for first analgesic
was longer in
dexmedetomidine
group (p 0.039)
-3mcg of
dexmedetomidine
added to
bupivacaine
prolonged
postoperative
analgesia
-mean time to
first analgesic
request was 345
minutes in control
group and 1360
minutes in
intervention
group

Three participants in the
control group required
fentanyl supplementation
during the procedure;
intervention not applied to
all participants
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Appendix E
Table 1
Abdelhamid SA, El-lakany MH (2013) Intrathecal dexmedetomidine: Useful or not? J
Anesth Clin Res 4:351.
Purpose
-Evaluate role of
dexmedetomidine
when added to heavy
bupivacaine
-assess time to require
first analgesic
-assess total analgesic
consumption

Setting
-Approved by the
Ethical
Committee of the
Medical Research
Institute of
Alexandria
University
Conducted at one
hospital

Sample
-62 patients
presenting for
inguinal hernia
repair
-during period of
January 1, 2013 to
end of March 2013
-ages 18-60
-exclusion criteria:
neurological
disease,
coagulopathy,
cardiac disease,
obesity,
hypertension

Design Method
-patients
randomized into
one of two groups
using sealed
envelope technique
-group one: 3.5ml
of hyperbaric
bupivacaine and
5mcg of
dexmedetomidine
-Group two:
normal saline
added to
hyperbaric
bupivacaine
-first time to
require analgesia
was recorded
-total analgesic
consumption was
recorded over 24
hours

Table 2
Procedure
-25-gauge
pencil point
spinal needle
was inserted
through L4-L5
interspace
-Injections
given over 10
seconds

Pain Scale
Used
-no pain scale
used
-results were
assessed by
evaluating time
to analgesic
request

Results

Limitations

-analgesia
-no pain scale was used
requirements lower -no information on how pain
in group D
assessment was conducted
(p<0.0001)
-total analgesic
consumption was
lower in group D
(p<0.0001)
-mean time to first
analgesic in group
1 was 259 min, and
381 min in group 2
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Appendix F
Table 1
Yektaş, A., & Belli, E. (2014). The effects of 2 μg and 4 μg doses of dexmedetomidine in
combination with intrathecal hyperbaric bupivacaine on spinal anesthesia and its
postoperative analgesic characteristics. Pain Research & Management: The
Journal of the Canadian Pain Society, 19(2), 75–81.
Purpose
-compare
postoperative
analgesic
characteristics of
dexmedetomidine
added to hyperbaric
bupivacaine
-compare side effects
when
dexmedetomidine is
added to intrathecal
bupivacaine
-evaluate effects of
intrathecal
dexmedetomidine on
spinal anesthesia

Setting
-study was approved
by the local ethics
committee of First
University Medical
Faculty of Turkey
-conducted in a
military hospital

Sample
-60 male patients
undergoing inguinal
surgery
-between 20-30
years old
-exclusion criteria:
addicted to drugs,
required additional
analgesia, sedation
during previous
procedures,
experienced pain
with previous
procedures, patients
whom they were
unable to obtain
CSF, and patients
whose level of
education was below
graduation from
primary school

Design Method
-patients were
randomly divided
into three groups
-Group 1: 15mg of
hyperbaric
bupivacaine plus
0.5ml saline
-Group 2: 15mg of
hyperbaric
bupivacaine plus 2
mcg
dexmedetomidine
-Group 3: 15mg of
hyperbaric
bupivacaine plus
4mcg
dexmedetomidine
-pain onset time in
postoperative period
was recorded
-total amount of
analgesic medication
for 24 hours was
recorded

Table 2
Procedure
-patient in
sitting position;
25-gauge
Quincke spinal
needle inserted
into the L4-L5
disc space

Pain Scale
Used
-numerical
pain rating
scale

Results

Limitations

-time to initiation of pain
was significantly longer in
group 3 than in both groups
1 and 2 (P<0.001)
-analgesic medication
consumption over 24 hours
was significantly higher in

None stated
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-when CSF
flow observed,
prepared
medical
solution was
injected

group 1 than in groups 2 and
3 (P<0.001)
-mean time to first analgesic
in group 1 was 220 min.,
group 2 371 min., and group
3 1042 min
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Appendix G
Table 1
Bi, Y.-H., Cui, X.-G., Zhang, R.-Q., Song, C.-Y., & Zhang, Y.-Z. (2017). Low dose of
dexmedetomidine as an adjuvant to bupivacaine in cesarean surgery provides
better intraoperative somato-visceral sensory block characteristics and
postoperative analgesia. Oncotarget, 8(38), 63587–63595.
Purpose
Measure effects of
lower doses of
dexmedetomidine
with intrathecal
bupivacaine on
postoperative pain

Setting
-approved by the
institutional ethics
committee in
China

Sample
-60 participants
-women of ASA
physical status 1 or
2
-pregnant and
receiving spinal
anesthesia for
elective c-section
-ages 18-40
-exclusion criteria:
history of opioid
use or NSAIDS,
psychiatric
disorders,
preoperative HR
<50 bpm,
neuromuscular or
endocrine disease,
or allergy to alpha
2 agonists

Design Method
-prospective,
randomized, double
blind study
-a computer
generated
randomization table
was used
-Bup Group: 10mg
bupivacaine alone
-Bup+Dex3 Group:
10mg bupivacaine
with 3mcg
dexmedetomidine
-Bup+Dex5 Group:
10mg bupivacaine
with 5mcg
dexmedetomidine

Table 2
Procedure

Pain Scale
Used
-lumbar epidural -VAS
anesthesia was
-assessed 6 and
induced
12 hours after
-spinal injection surgery
performed with -first rescue
a 25-gauge
analgesia drug
pencil point
time was
needle and
recorded
injection was
made

Results

Limitations

-VAS at 6 hours was higher None stated
in Bup Group than the other
two groups (P=0.0032)
-No difference was observed
at 12 hours (P=0.3533)
-time to first postoperative
supplemental drug
administration was not
significantly different
(P=0.7096)
-mean time to first analgesic:
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-study drugs
were injected at
a rate of
1ml/15sec
-same
anesthesiologist
administered
each spinal

Bup Group: 1320
min
Bup+Dex3: 1488
min
Bup+Dex5: 1428
min
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Appendix H
Table 1
Salem, R.A., Darweesh, E.I., Wanis, M.A., & Mohamed, A.A. (2015). Evaluation of the
effects of intrathecal bupivacaine-dexmedetomidine for lumbar spine fusion: a
double blinded randomized controlled study. European Review for Medical and
Pharmacological Sciences, 19, 4542-4548.
Purpose
-evaluate efficacy of
intrathecal
dexmedetomidine at
improving
postoperative
analgesia during
spinal surgery
-also investigated
effects of
dexmedetomidine
on patient
hemodynamics

Setting
-approved by the
Ethics and
Research
Committee of
Sohag Faculty
Faculty of
Medicine, Sohag
University
-conducted at
Sohag University
Hospital
-August 2012-July
2014

Sample
-52 patients
-ages 40-65 years
-ASA physical
status 1 or 2
-scheduled for onelevel posterolateral
lumbar spine fusion
-exclusion criteria:
contraindication for
spinal anesthesia,
known allergy to
study drugs,
treatment with
alpha adrenergic
antagonists, labile
hypertension,
cardiac
dysrhythmias,
coronary artery
disease, renal or
hepatic impairment,
neurological
disorder, or
bleeding diathesis

Design Method
-prospective,
randomized, doubleblind, placebocontrolled clinical
study
-participants were
randomized using
sequentially
numbered closed
envelopes
-Group D: 15mg
hyperbaric
bupivacaine with
5mcg of
dexmedetomidine
-Group P: 15mg
hyperbaric
bupivacaine with
0.5ml saline
-time to first
requirement of
analgesia was
recorded
-total dose of
analgesic
medication over 24
hours was recorded

Table 2
Procedure
-Lumbar
puncture
performed with
patient in sitting

Pain Scale
Used
-no pain scale
used
-results were
assessed by

Results
-time to first
analgesic
request was
significantly

Limitations
None stated
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position at L3evaluating time
L4 intervertebral to analgesic
disc space
request
-25-gauge
needle
-same surgeon
performed all
operations
-same
anesthesiologist
performed all
spinals

longer in group
D (p<0.0001)
-total dose of
total analgesic
medication over
24 hours was
smaller in
group D
(p<0.0001)
-mean time to
first analgesic
in group P was
269 min, and
group D was
399 min
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Appendix I
Table 1
Patro, S.S., Deshmukh, H., Ramani, Y.R., & Das, G. (2016). Evaluation of
dexmedetomidine as an adjuvant to intrathecal bupivacaine in infraumbilical
surgeries. Journal of Clinical and Diagnostic Research, 10(3), 13-16.
Purpose
-evaluate efficacy of
intrathecal
dexmedetomidine as
an adjuvant to
bupivacaine in
spinal anesthesia in
patients undergoing
infraumbilical
surgery

Setting
-study approved by
Institutional Ethics
Committee of
Odisha, India
-conducted at one
hospital
-over a 2-month
period

Sample
-60 adult patients
of either sex
-ages 18-45
-ASA 1 and 2
-exclusion criteria:
coagulation
disorders,
neurologic
disorders

Design Method
-prospective, double
blind
-randomly allocated
into two groups
using sealed
envelope technique
-Group I: 3ml of
0.5% hyperbaric
bupivacaine and
0.5ml normal saline
-Group II: 3ml of
0.5% hyperbaric
bupivacaine with
5mcg
dexmedetomidine
-level of analgesia in
postoperative period
was recorded

Pain Scale Used
-VAS

Results
-significant
difference in
duration of
complete analgesia
observed between
two groups
-intra-operative
VAS was <3 in
both groups
-after three hours
VAS 0.03 in Group
II and 1.03 in
Group I
-after six hours
VAS 2.67 in Group

Limitations
-small sample size
-2-month period

Table 2
Procedure
-surgery was
approximately one
and a half hour
-medication
prepared by
anesthesiologist not
involved in study
-lumbar puncture
performed in left
lateral position
-25 gauge Quincke
needle inserted at
L3-L4 intervertebral
space
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-3.5ml of preprepared drug
administered
-infraumbilical
surgeries:
hysterectomy, hernia
repairs,
appendectomy, open
urosurgical
procedures

II and 3.7 in Group
I (p<0.001)
-mean time to first
analgesic in group I
was 193.6 min,
group II was 333.6
min
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Appendix J
Kim, J.E., Kim, N.Y., Lee, H.S., & Kil, H.K. (2013). Effects of intrathecal
dexmedetomdine on low-dose bupivacaine spinal anesthesia in elderly patients
undergoing transurethral prostatectomy. The Pharmaceutical Society of Japan,
36(6), 959-965.
Yes
1

2

3

4

5

6

Did the trial address a clearly focused issue? Evaluate
adjuvant effects of intrathecal dexmedetomidine in elderly
patients undergoing TURP surgery with low-dose
bupivacaine spinal anesthesia. Patients divided into two
groups: a group that received 3mcg of dexmedetomidine
combined with 6mg of hyperbaric bupivacaine, and
another group that received the same amount of NS and
bupivacaine.
Was the assignment of patients to treatments
randomized? 54 elderly patients undergoing TURP
included in the study and placed into one of two groups by
random number sequence.
Were all the patients who entered the trial properly
accounted for at its conclusion? Yes, no patients
dropped out.
Were patients, health workers and study personnel
‘blind’ to treatment? An independent investigator
prepared the drug solutions that were coded and provided
to anesthetic administrator. Anesthetic administrator,
patients, outcome assessors, and data analysts blinded to
the allocation.
Were the groups similar at the start of the trial?
Patients were undergoing the same surgery with the same
anesthetic technique. 39/54 participants had more than one
systemic disease such as hypertension (24), diabetes (13),
coronary disease (8), cerebrovascular accident (5),
arrhythmia (3), liver cirrhosis (3), COPD (3), and chronic
renal failure (2). No ASA status listed, no gender
differentiation, and no ages stated.
Aside from the experimental intervention, were the
groups treated equally? Each patient followed for one
month after the procedure to assess for possible neurologic

Can’t No
Tell

ü

ü

ü

ü

ü

ü
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effects. An independent coordinator interviewed all
patients a week after discharge. At one month, coordinator
interviewed each patient. Patient’s assessed for new
unusual sensations on the back, buttock, or legs.
7 How large was the treatment effect? The
dexmedetomidine group showed a lower postoperative
analgesic requirement compared to the saline group
(p<0.01). Analysis of time to first request of analgesic
medication showed a significant difference between the
two groups (p=0.006). In the dexmedetomidine group
postoperative analgesic request was significantly lower at
the 7-day follow up (p<0.01).
8 How precise was the estimate of the treatment effect?
Study calculated that a sample size of 23 patients per group
would be required for a power level of 80% and a
significance level of 0.05.
9 Can the results be applied in your context? (or to the
local population?) Study’s findings were appropriate for
this systematic review.
10 Were all clinically important outcomes considered?
Postoperative analgesia levels recorded in both groups at
multiple time intervals. Time to first analgesic request was
recorded for each participant.
11 Are the benefits worth the harms and costs? No
adverse outcomes were noted; the benefits outweigh the
risks.

ü

ü

ü

ü

ü
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Appendix K
Abdelhamid SA, El-lakany MH (2013) Intrathecal dexmedetomidine: Useful or not? J
Anesth Clin Res 4:351.
Yes
1

2
3
4

5

6

7

8

Did the trial address a clearly focused issue? Purpose
was to evaluate effects of adding dexmedetomidine to
hyperbaric bupivacaine intrathecally. End-points were
block characteristics among studied groups, analgesic
needs, and intra-operative assessment of blood pressure
and heart rate.
Was the assignment of patients to treatments
randomized? Patients were randomly divided using
sealed envelope technique.
Were all the patients who entered the trial properly
accounted for at its conclusion? All 62 patients finished
study.
Were patients, health workers and study personnel
‘blind’ to treatment? This was a double blinded
randomized control trial. Medications were prepared by a
third party.
Were the groups similar at the start of the trial?
Patients were excluded if they had any major illnesses.
They were all ASA 1 or 2 status. Weights were similar,
between 65-68 kilograms. The only characteristic that
varied significantly was age, which ranged from 22-56.
Aside from the experimental intervention, were the
groups treated equally? Each group was monitored
throughout procedure for adverse events. Postoperatively
they were monitored for complications including nausea,
vomiting, shivering, bradycardia, and hypotension.
How large was the treatment effect? Time to first
required analgesic medication in intervention group
obtained a p value of <0.0001. Total analgesic
consumption for intervention group obtained a p value of
<0.0001.
How precise was the estimate of the treatment effect?
Significance of the results was at the 5% level of
significance. For the intervention group, time to first
analgesic request had a significance level of Z=6.81 and
total analgesic consumption has a significance level of
Z=6.818

Can’t No
tell

ü

ü
ü
ü

ü

ü

ü

ü
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9
10

11

Can the results be applied in your context? (or to the
local population?) Findings were appropriate for this
systematic review.
Were all clinically important outcomes considered?
Immediate outcomes were considered and evaluated, but
nothing beyond immediate post-operative period was
assessed. There was no documented follow-up with any
participants.
Are the benefits worth the harms and costs? Although
there were positive analgesia results in both groups, there
were also complications noted. No financial information
noted so it is difficult to determine if the benefit of
improved postoperative analgesia outweighed the risk of
harm and cost.

ü
ü

ü
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Appendix L
Bi, Y.-H., Cui, X.-G., Zhang, R.-Q., Song, C.-Y., & Zhang, Y.-Z. (2017). Low dose of
dexmedetomidine as an adjuvant to bupivacaine in cesarean surgery provides
better intraoperative somato-visceral sensory block characteristics and
postoperative analgesia. Oncotarget, 8(38), 63587–63595.
Yes
1

2
3

4

5

6

7

8

Did the trial address a clearly focused issue? Investigate
the beneficial effects of dexmedetomidine on postoperative
analgesia when combined with intrathecal bupivacaine.
Spinal anesthesia is commonly used for c-sections, but
there remains a lack of long-lasting postoperative
analgesia.
Was the assignment of patients to treatments
randomized? A computer-generated randomization table
was used to divide the participants into groups.
Were all the patients who entered the trial properly
accounted for at its conclusion? If spinal anesthesia
failed, participants would be excluded, but the study does
not identify how many participants were excluded; they
did not specify how many participants finished the study.
Were patients, health workers and study personnel
‘blind’ to treatment? Medication prescriptions were kept
in a sealed envelope, and medication was prepared by a
registered anesthetic nurse who was not involved in the
study. All employees contributing to study were blinded.
Were the groups similar at the start of the trial?
Demographic profiles of participants were similar
regarding age, weight, height, gestation age, and mean
duration of surgery.
Aside from the experimental intervention, were the
groups treated equally? Following procedure, all
participants were advised to avoid breastfeeding for 24
hours; there are no published studies on the safety of
breastfeeding after spinal dexmedetomidine. Side
effects/complications were treated equally in each
participant.
How large was the treatment effect? VAS at 6 hours
was higher in Bup Group than the other two groups
(P=0.0032).
No difference was observed at 12 hours (P=0.3533).
How precise was the estimate of the treatment effect?
P-value less than 0.05 was considered statistically
significant.

Can’t No
tell

ü

ü
ü

ü

ü

ü

ü

ü
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9
10

11

Can the results be applied in your context? (or to the
local population?) Findings were appropriate for this
systematic review.
Were all clinically important outcomes considered?
Along with postoperative analgesia, other outcomes
assessed include fetal well-being, spinal block
characteristics, side effects, and maternal stress response.
Are the benefits worth the harms and costs? There were
clear benefits on postoperative analgesia and no harm
towards the fetus or mother. Cost analysis was not
evaluated.

ü

ü
ü
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Appendix M
Patro, S.S., Deshmukh, H., Ramani, Y.R., & Das, G. (2016). Evaluation of
dexmedetomidine as an adjuvant to intrathecal bupivacaine in infraumbilical
surgeries. Journal of Clinical and Diagnostic Research, 10(3), 13-16.
Yes
1

2
3
4
5
6
7
8
9
10
11

Did the trial address a clearly focused issue? Evaluate
efficacy of intrathecal dexmedetomidine as an adjuvant to
bupivacaine in spinal anesthesia in patients undergoing
infraumbilical surgery. Patients divided into two groups:
group I received hyperbaric bupivacaine with normal
saline, group II received hyperbaric bupivacaine with
dexmedetomidine.
Was the assignment of patients to treatments
randomized? Patients were randomly allocated into two
groups using sealed envelope technique.
Were all the patients who entered the trial properly
accounted for at its conclusion? Yes, no patients dropped
out.
Were patients, health workers and study personnel
‘blind’ to treatment? Medication was prepared by an
anesthesiologist not included in study. Double blind study.
Were the groups similar at the start of the trial?
Demographics were comparable with respect to age, sex,
weight, height, duration, and type of surgery.
Aside from the experimental intervention, were the
groups treated equally? All participants were treated
equally regarding side effects/adverse events.
How large was the treatment effect? Postoperative VAS
ratings were significantly different at 6 hours between the
two groups, p<0.001.
How precise was the estimate of the treatment effect?
P value <0.05 was considered significant.
Can the results be applied in your context? (or to the
local population?) Findings were appropriate for this
systematic review.
Were all clinically important outcomes considered?
Time to first analgesic request was recorded; VAS ratings
were recorded at 3 hours, 6 hours, and 12 hours postop.
Are the benefits worth the harms and costs? Benefits of
dexmedetomidine on postoperative analgesia were clear;
cost analysis was not performed.

Can’t No
tell

ü

ü
ü

ü
ü
ü
ü
ü
ü
ü
ü
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Appendix N
Salem, R.A., Darweesh, E.I., Wanis, M.A., & Mohamed, A.A. (2015). Evaluation of the
effects of intrathecal bupivacaine-dexmedetomidine for lumbar spine fusion: a
double blinded randomized controlled study. European Review for Medical and
Pharmacological Sciences, 19, 4542-4548.
Yes
1
2
3
4

5
6
7

8
9
10
11

Did the trial address a clearly focused issue? Evaluate
efficacy of intrathecal dexmedetomidine at improving
postoperative analgesia during spinal surgery.
Was the assignment of patients to treatments
randomized? Randomization and enrollment were
performed using sequentially numbered closed envelopes.
Were all the patients who entered the trial properly
accounted for at its conclusion? 52 participants were
present at the start, and 52 participants at the conclusion
Were patients, health workers and study personnel
‘blind’ to treatment? This was a double blinded study.
One anesthesiologist performed the spinal blocks while
another followed the patients postoperatively. Both
anesthesiologists were blinded to group allocation.
Were the groups similar at the start of the trial? Patient
demographic data did not differ between the two study
groups
Aside from the experimental intervention, were the
groups treated equally? No other information was
provided on group treatment.
How large was the treatment effect? Time to first
analgesic request was significantly longer in group D
(p<0.0001). Total dose of total analgesic medication over
24 hours was smaller in group D (p<0.0001)
How precise was the estimate of the treatment effect?
Level of statistical significance was considered at p<0.05
Can the results be applied in your context? (or to the
local population?) Findings were appropriate for this
systematic review.
Were all clinically important outcomes considered?
Time to first analgesic request was recorded, as well as total
dose of analgesic medications.
Are the benefits worth the harms and costs? No adverse
outcomes were noted in the intervention group; benefits
outweigh the risks. Cost analysis was not done.

Can’t No
tell
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ü
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Appendix O
Yektaş, A., & Belli, E. (2014). The effects of 2 μg and 4 μg doses of dexmedetomidine in
combination with intrathecal hyperbaric bupivacaine on spinal anesthesia and its
postoperative analgesic characteristics. Pain Research & Management : The
Journal of the Canadian Pain
Yes
1

2
3
4
5

6

7

8
9
10

Did the trial address a clearly focused issue? Evaluated
different doses of intrathecal dexmedetomidine and
whether they had effects on properties of hyperbaric
bupivacaine. Goal was to prolong postoperative analgesia
while providing quality anesthesia.
Was the assignment of patients to treatments
randomized? Patients were randomly divided into three
groups.
Were all the patients who entered the trial properly
accounted for at its conclusion? 60 male patients
participated and were present at conclusion of study.
Were patients, health workers and study personnel
‘blind’ to treatment? Double-blind study.
Were the groups similar at the start of the trial? Ages
were between 20-30, all ASA status 1. Mean weight
among participants in group 1, 2, and 3 were 72 kg, 72 kg,
and 73 kg respectively. Mean height among participants in
group 1, 2, and 3 were 174 cm, 173 cm, and 172 cm
respectively.
Aside from the experimental intervention, were the
groups treated equally? Each participant was monitored
throughout procedure in the same manner. Surgery
duration was 20 minutes for each participant. Side effects
were treated symptomatically with the same interventions.
How large was the treatment effect? Time to pain onset
obtained a P value of <0.001. Amount of analgesic
medication consumption over 24 hours obtained a P value
of <0.001.
How precise was the estimate of the treatment effect? P
< 0.05 was considered statistically significant.
Can the results be applied in your context? (or to the
local population?) Findings were appropriate for this
systematic review.
Were all clinically important outcomes considered?
Analgesic requirements, side effects, and complications
were all considered.

ü

ü
ü
ü
ü

ü

ü

ü
ü
ü

Can’t No
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11

Are the benefits worth the harms and costs? This study
found clear benefits of using dexmedetomidine with
hyperbaric bupivacaine intrathecally with no additional
harm to the patient, but cost analysis was not evaluated.

ü
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Appendix P
Authors

Procedure/Type Pain Scale
of surgery
Used

Dosage
Used
(mcg)

Kim et al.,
2013

Transurethral
prostatectomy

VAS

Abdelhamid
& El-lakany,
2013

Lower
abdominal
surgery

Yektaş, A., & Inguinal surgery
Belli, E.,
2014

Intervention
Group- mean
time to first
analgesic
request
(minutes)

3 mcg

Control
Groupmean time
to first
analgesic
request
(minutes)
345

No scale;
results
were
assessed
by
evaluating
time to
analgesic
request
Numerical
pain rating
scale

5 mcg

259

381

2 mcg
&
4 mcg

220

-group 2: 371
-group 3:
1042

1360

Bi et al.,
2017

Cesarian section

VAS

3 mcg
&
5mcg

1320

-Bup+Dex3
Group: 1488
-Bup+Dex5
Group: 1428

Salem, R.A.
et al., 2015

Posterolateral
lumbar spine
fusion

5 mcg

269

399

Patro et al.,
2016

Infra-umbilical
surgeries

No scale;
results
were
assessed
by
evaluating
time to
analgesic
request
VAS

5 mcg

193.6

333.6

reaurest

time to
analgesic
request

